Home
Storia in 2 fonti
Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
Eli Lilly now has the clinical trial data required to start filing for approvals of the drug for chronic weight management with global regulators.
- ·
cnbc.com
Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
Eli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk, including a lack of dietary restrictions and easier manufacturing.
- ·
Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
Eli Lilly now has the clinical trial data required to start filing for approvals of the drug for chronic weight management with global regulators.
- ·
ft.com
Eli Lilly’s weight-loss pill meets target in key diabetes trial
Results from US pharma group show oral drug reduced body weight by 10.5% on average